Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally. It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities. It also offers corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Metrics to compare | 1312 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1312PeersSector | |
---|---|---|---|---|
P/E Ratio | −2.1x | 6.0x | −0.6x | |
PEG Ratio | 0.01 | 0.04 | 0.00 | |
Price/Book | 0.2x | 1.1x | 2.6x | |
Price / LTM Sales | 0.2x | 1.8x | 3.3x | |
Upside (Analyst Target) | - | 33.3% | 39.1% | |
Fair Value Upside | Unlock | 14.1% | 5.4% | Unlock |